Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
Lancet Infect Dis. 2023 Mar;23(3):352-360. doi: 10.1016/S1473-3099(22)00594-1. Epub 2022 Oct 20.
Lancet Infect Dis. 2023.
PMID: 36273490
Free article.
Clinical Trial.
Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children.
Ishola D; EBOVAC-Salone Malaria Infection (MALI) Sub-Study Team.
Ishola D, et al.
Clin Infect Dis. 2022 Oct 29;75(9):1585-1593. doi: 10.1093/cid/ciac209.
Clin Infect Dis. 2022.
PMID: 35640636
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite